Kazuto Nosaka

Feasibility and Benefit of Concurrent Chemoradiotherapy for Elderly Patients with Uterine Cervical Cancer

H. Kajiyama, F. Kikkawa, K. Shibata, 2016, Tumori.

Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial

I. Endo, T. Sasada, S. Wada, 2019, Cancer science.

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer

Yuki Saito, S. Mizuno, Y. Nakamoto, 2020, Cancer science.

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors

A. Manabe, K. Yoshimura, A. Hosono, 2017, Oncoimmunology.

Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer

H. Kajiyama, F. Kikkawa, T. Nakatsura, 2021, AntiCancer Research.

New Candidate Preservative in Ophthalmic Solution Instead of Benzalkonium Chloride: 1,3-Didecyl-2-methyl Imidazolium Chloride.

R. Uchiyama, Takuya Iwasaki, Kazuto Nosaka, 2023, Chemical & pharmaceutical bulletin.